FFCP PHASE1:Mm9::chr12:29808161..29808203,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=146|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:29808161..29808203,+|id=chr12:29808161..29808203,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002369!4.71e-52!7;UBERON:0006858!4.71e-52!7;UBERON:0002342!2.19e-36!10;UBERON:0005062!2.19e-36!10;UBERON:0003064!6.42e-26!14;UBERON:0005157!2.88e-13!27;UBERON:0005172!3.68e-09!49;UBERON:0005173!3.68e-09!49;UBERON:0002417!3.68e-09!49;UBERON:0000916!3.68e-09!49;UBERON:0005256!2.04e-07!47|ontology_enrichment_uberon_v019_2=UBERON:0002369,2.40e-74,7;UBERON:0006858,2.40e-74,7;UBERON:0003064,1.49e-37,14;UBERON:0005256,4.78e-12,45;UBERON:0005172,4.27e-11,49;UBERON:0005173,4.27e-11,49;UBERON:0002417,4.27e-11,49;UBERON:0000916,4.27e-11,49;UBERON:0002368,3.96e-09,60;UBERON:0003104,5.52e-09,61;UBERON:0009142,5.52e-09,61;UBERON:0002530,1.88e-08,65;UBERON:0009569,2.50e-08,66;UBERON:0000949,1.17e-07,72;UBERON:0005177,5.28e-07,79|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.90652834388949,3.99016251562112,1.52232739156071,1.38369298353635,1.65794904607885,0.823120949949934,2.26199864393416,0,0,0,0,0,0,0,0.292780797011547,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.474529061544512,0,0,0,0,0,0,0,0,0.228497025219458,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.165458490457098,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.243106717068294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:29808161..29808203,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=146 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:29808161..29808203,+ | |||
|description=CAGE_peak_at_chr12:29808161..29808203,+ | |||
|id=chr12:29808161..29808203,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002369!4.71e-52!7;UBERON:0006858!4.71e-52!7;UBERON:0002342!2.19e-36!10;UBERON:0005062!2.19e-36!10;UBERON:0003064!6.42e-26!14;UBERON:0005157!2.88e-13!27;UBERON:0005172!3.68e-09!49;UBERON:0005173!3.68e-09!49;UBERON:0002417!3.68e-09!49;UBERON:0000916!3.68e-09!49;UBERON:0005256!2.04e-07!47 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002369,2.40e-74,7;UBERON:0006858,2.40e-74,7;UBERON:0003064,1.49e-37,14;UBERON:0005256,4.78e-12,45;UBERON:0005172,4.27e-11,49;UBERON:0005173,4.27e-11,49;UBERON:0002417,4.27e-11,49;UBERON:0000916,4.27e-11,49;UBERON:0002368,3.96e-09,60;UBERON:0003104,5.52e-09,61;UBERON:0009142,5.52e-09,61;UBERON:0002530,1.88e-08,65;UBERON:0009569,2.50e-08,66;UBERON:0000949,1.17e-07,72;UBERON:0005177,5.28e-07,79 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.90652834388949,3.99016251562112,1.52232739156071,1.38369298353635,1.65794904607885,0.823120949949934,2.26199864393416,0,0,0,0,0,0,0,0.292780797011547,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.474529061544512,0,0,0,0,0,0,0,0,0.228497025219458,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.165458490457098,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.243106717068294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:29808161..29808203,+ | |||
}} |
Latest revision as of 23:03, 4 August 2015
Short description: | p@chr12:29808161..29808203, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:29808161..29808203, + |
Coexpression cluster: | MCL_coexpression_mm9:146 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
adrenal gland | 2.40e-74 | 7 |
adrenal/interrenal gland | 2.40e-74 | 7 |
intermediate mesoderm | 1.49e-37 | 14 |
trunk mesenchyme | 4.78e-12 | 45 |
abdomen element | 4.27e-11 | 49 |
abdominal segment element | 4.27e-11 | 49 |
abdominal segment of trunk | 4.27e-11 | 49 |
abdomen | 4.27e-11 | 49 |
endocrine gland | 3.96e-09 | 60 |
mesenchyme | 5.52e-09 | 61 |
entire embryonic mesenchyme | 5.52e-09 | 61 |
gland | 1.88e-08 | 65 |
subdivision of trunk | 2.50e-08 | 66 |
endocrine system | 1.17e-07 | 72 |
trunk region element | 5.28e-07 | 79 |